These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 17124341)

  • 1. NMO-IgG: a specific biomarker for neuromyelitis optica.
    Weinshenker BG; Wingerchuk DM; Pittock SJ; Lucchinetti CF; Lennon VA
    Dis Markers; 2006; 22(4):197-206. PubMed ID: 17124341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromyelitis optica: clinical syndrome and the NMO-IgG autoantibody marker.
    Weinshenker BG; Wingerchuk DM
    Curr Top Microbiol Immunol; 2008; 318():343-56. PubMed ID: 18219825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
    Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
    Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.
    Magaña SM; Pittock SJ; Lennon VA; Keegan BM; Weinshenker BG; Lucchinetti CF
    Arch Neurol; 2009 Aug; 66(8):964-6. PubMed ID: 19667216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
    Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL
    Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases].
    Kira J
    Rinsho Shinkeigaku; 2010 Nov; 50(11):788-93. PubMed ID: 21921443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromyelitis optica.
    Wingerchuk DM
    Int MS J; 2006 May; 13(2):42-50. PubMed ID: 16635421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revised diagnostic criteria for neuromyelitis optica.
    Wingerchuk DM; Lennon VA; Pittock SJ; Lucchinetti CF; Weinshenker BG
    Neurology; 2006 May; 66(10):1485-9. PubMed ID: 16717206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.
    Lennon VA; Wingerchuk DM; Kryzer TJ; Pittock SJ; Lucchinetti CF; Fujihara K; Nakashima I; Weinshenker BG
    Lancet; 2004 Dec 11-17; 364(9451):2106-12. PubMed ID: 15589308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromyelitis optica.
    Matiello M; Jacob A; Wingerchuk DM; Weinshenker BG
    Curr Opin Neurol; 2007 Jun; 20(3):255-60. PubMed ID: 17495617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
    Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
    Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expanded spectrum of neuromyelitis optica: evidences for a new definition.
    Lana-Peixoto MA; Callegaro D
    Arq Neuropsiquiatr; 2012 Oct; 70(10):807-13. PubMed ID: 23060108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders.
    Kira J
    J Neurol Sci; 2011 Dec; 311(1-2):69-77. PubMed ID: 21962794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
    Misu T; Fujihara K; Itoyama Y
    Brain Nerve; 2008 May; 60(5):527-37. PubMed ID: 18516975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.
    Juryńczyk M; Weinshenker B; Akman-Demir G; Asgari N; Barnes D; Boggild M; Chaudhuri A; D'hooghe M; Evangelou N; Geraldes R; Illes Z; Jacob A; Kim HJ; Kleiter I; Levy M; Marignier R; McGuigan C; Murray K; Nakashima I; Pandit L; Paul F; Pittock S; Selmaj K; de Sèze J; Siva A; Tanasescu R; Vukusic S; Wingerchuk D; Wren D; Leite I; Palace J
    J Neurol; 2016 Jan; 263(1):140-9. PubMed ID: 26530512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica.
    Takahashi T; Fujihara K; Nakashima I; Misu T; Miyazawa I; Nakamura M; Watanabe S; Ishii N; Itoyama Y
    Tohoku J Exp Med; 2006 Dec; 210(4):307-13. PubMed ID: 17146196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and classification of neuromyelitis optica (Devic's syndrome).
    Drori T; Chapman J
    Autoimmun Rev; 2014; 13(4-5):531-3. PubMed ID: 24424197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Devic's neuromyelitis optica: diagnosis after 10 years of bilateral severe relapsing optic neuritis].
    Déral-Stéphant V; Roux-Lelièvre C; Vignal R; Stéphant E; Faivre A; Alla P
    J Fr Ophtalmol; 2008 Sep; 31(7):705-9. PubMed ID: 18971856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders.
    Jacob A; McKeon A; Nakashima I; Sato DK; Elsone L; Fujihara K; de Seze J
    J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):922-30. PubMed ID: 23142960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience.
    Harirchian MH; Tafakhori A; Taslimi S; Aghamollaii V; Shahsiah R; Gholipour T; Mohammadi F; Zare-Shahabadi A
    Iran J Allergy Asthma Immunol; 2015 Feb; 14(1):98-104. PubMed ID: 25530145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.